Search research articles
Contact Us
Filters
Showing results (111-120 of 186) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report
Brigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Pediatric Blood & Cancer
|
March 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)
Emily Greengard, Robin Williams, Branden Moriarity, et al.
The Lancet. Oncology
|
November 3, 2022
ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome
Brigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma
Elizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2007
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis
Ronald J Bernardi, Lisa Bomgaars, Elizabeth Fox, et al.
Pediatric Blood & Cancer
|
September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
AeRang Kim, Eva Dombi, Kathleen Tepas, et al.
Neuro-Oncology Advances
|
June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study
Sabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
Journal of the National Cancer Institute
|
November 17, 2023
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
Brigitte C Widemann, Wanda L Salzer, Robert J Arceci, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 186) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report
Brigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Pediatric Blood & Cancer
|
March 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)
Emily Greengard, Robin Williams, Branden Moriarity, et al.
The Lancet. Oncology
|
November 3, 2022
ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome
Brigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma
Elizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2007
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis
Ronald J Bernardi, Lisa Bomgaars, Elizabeth Fox, et al.
Pediatric Blood & Cancer
|
September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
AeRang Kim, Eva Dombi, Kathleen Tepas, et al.
Neuro-Oncology Advances
|
June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study
Sabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
Journal of the National Cancer Institute
|
November 17, 2023
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
Brigitte C Widemann, Wanda L Salzer, Robert J Arceci, et al.
Page
of 19